Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 678.55K | 1.12M | 1.5M | 1.31M | 1.28M | 963.8K | 583.23K | 569.16K | 249.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 16.89K | 16.77K | 22.92K | 16.45K | 16.45K | 11.14K | 5.4K | 410.00 | 61.78K | 125.47K | 188.83K | 254.82K | 262.9K | 259.44K | 271.68K | 205.69K | 136.24K | 76K |
Gross Profit | 819.3K | 1.26M | 1.48M | 1.29M | 1.26M | 952.66K | 577.84K | 568.75K | 187.91K | -125.47K | -188.83K | -254.82K | -262.9K | -259.44K | -271.68K | -205.69K | -136.24K | -76K |
Operating Income | -14.8M | -15.26M | -14.32M | -14.77M | -14.19M | -14M | -15.46M | -14.4M | -15.1M | 41.97M | 38.37M | 33.23M | 28.03M | -35.39M | -37.37M | -43.84M | -46.64M | -51.13M |
Interest Income | 1.01M | 1.21M | 1.29M | 1.32M | 1.3M | 1.25M | 1.22M | 1.16M | 986.84K | 703.11K | 446.7K | 206.94K | 55.82K | 3.33K | 3.33K | 0.00 | 0.00 | 0.00 |
Pretax Income | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -109.11M | -112.66M | -117.98M | -123.4M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Net Income | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.06M | -121.4M | -122.37M | -217.42M | -221.21M | -118.18M | -123.46M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Selling & General & Admin | 6.04M | 6.29M | 6.45M | 7.01M | 7.13M | 6.98M | 8.42M | 8.9M | 10.27M | 24.2M | 24.82M | 26.07M | 26.4M | 14.11M | 13.55M | 15.08M | 15.14M | 15.58M |
Research & Development | 9.6M | 10.25M | 9.36M | 9.05M | 8.33M | 7.97M | 7.63M | 6.11M | 5.11M | 9.72M | 12.55M | 16.48M | 21.38M | 21.22M | 23.9M | 28.76M | 31.51M | 35.55M |
Other Expenses | -360.05K | -360.05K | -360.05K | -354.62K | -319.47K | -319.47K | -319.47K | -319.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.28M | 16.17M | 15.45M | 15.71M | 15.13M | 14.38M | 15.48M | 14.45M | 15.13M | 33.92M | 37.37M | 42.55M | 47.78M | 35.33M | 37.45M | 43.84M | 46.64M | 51.13M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 297.54K | 448.67K | 501.16K | 503.13K | 208.91K | 57.82K | 5.92K | 5K | 6.42K | 15.6K | 17.69K |
Selling & Marketing Expenses | n/a | -5.3K | -11.46K | -16.45K | -16.45K | -11.14K | -4.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.28M | 16.19M | 15.47M | 15.72M | 15.15M | 14.39M | 15.49M | 14.45M | 15.13M | 33.92M | 37.37M | 42.55M | 47.78M | 35.33M | 37.45M | 43.84M | 46.64M | 51.13M |
Income Tax Expense | n/a | -5 | -5 | -5 | -5 | n/a | -229.23K | 108.11M | 108.26M | 108.31M | 108.55M | 208.91K | 79.73K | 27.24K | 25.27K | 21.94K | 83.78K | 83.78K |
Shares Outstanding (Basic) | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.26M | 132.76K | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
Shares Outstanding (Diluted) | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.26M | 132.76K | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
EPS (Basic) | -2.32 | -2.37 | -2.38 | -2.81 | -3.03 | -3.32 | -3.92 | -837.43 | -838.98 | -924.87 | -930.85 | -103.62 | -110.11 | -33.03 | -34.91 | -42.24 | -44.97 | -50.8 |
EPS (Diluted) | -2.32 | -2.37 | -2.38 | -2.81 | -3.03 | -3.32 | -3.92 | -837.43 | -838.98 | -924.87 | -930.85 | -103.62 | -110.11 | -33.03 | -34.91 | -42.24 | -44.97 | -50.8 |
EBITDA | -14.79M | -15.24M | -14.3M | -14.52M | -13.95M | -13.76M | -14.99M | -14.17M | -14.61M | -33.34M | -36.84M | -41.91M | -47.33M | -35.14M | -36.85M | -44.5M | -47.37M | -53.5M |
EBIT | -14.49M | -15.1M | -14.32M | -14.54M | -13.96M | -13.77M | -15.24M | -14.45M | -15.13M | -33.92M | -37.37M | -42.55M | -47.78M | -35.33M | -37.45M | -43.84M | -46.64M | -51.13M |
Depreciation & Amortization | 16.29K | 21.59K | 22.32K | 21.88K | 17.88K | 12.8K | 7.05K | -319 | 59.62K | 123.09K | 186.44K | 254.82K | 262.9K | 259.44K | 271.68K | 262.58K | 249.82K | 237.84K |